O'Connor Law

Thursday, August 30, 2007

Fegley named First Vice Chair for AAJ

During the July 2007 American Association for Justice Convention in Chicago, Illinois, Attorney Wayne S. Fegley of Michael J. O’Connor & Associates located in Frackville, Pa was named First Vice Chair to the Workers’ Compensation section of the Association.
Formally the Association of Trial Lawyers of America, in December of 2006, ATLA members voted to change the association's name to the American Association for Justice (AAJ). Today, AAJ is a broad-based, international coalition of attorneys, law professors, paralegals, and law students. The mission of AAJ is to promote a fair and effective justice system – and to support the work of attorneys in their efforts to ensure that any person who is injured by the misconduct or negligence of others can obtain justice in America’s courtrooms, even when taking on the most powerful interests.

As the world's largest trial bar, AAJ promotes justice and fairness for injured persons, safeguards victims' rights--particularly the right to trial by jury--and strengthens the civil justice system through education and disclosure of information critical to public health and safety. With more than 56,000 members worldwide, and a network of U.S. and Canadian affiliates involved in diverse areas of trial advocacy, AAJ provides lawyers with the information and professional assistance needed to serve clients successfully and protect the democratic values inherent in the civil justice system.

The law firm of Michael J. O'Connor & Associates is dedicated to providing clients with the best legal help possible. They specialize in: workers' compensation, social security disability, personal injury, wage & hour violations, nursing home negligence and wills, estates & elder law. The firm recently celebrated 20 years of business. While the principal office is located in Frackville, Pa, the firm has thirteen other office sites conveniently located throughout the state of Pennsylvania. With offices located in Allentown, Bala Cynwyd, Bloomsburg, Frackville, Hazleton, Lancaster, Lock Haven, Reading, Scranton, State College, Stroudsburg, Sunbury, Wilkes-Barre and Williamsport, it is easy to accommodate clients from virtually anywhere in the state.

posted by Michael J. O'Connor & Associates at 11:34 AM

Erectile Dysfunction Drugs May Produce Many Side Effects

To date, there are only three FDA-approved drugs to treat erectile dysfunction (ED). The drugs Viagra, Cialis and Levitra work by increasing the flow of blood to the penis so that when a man is sexually stimulated, he can get an erection. All three drugs take approximately 15-30 minutes to take effect, but how long the drugs last varies. Viagra typically lasts about four hours; Levitra about five hours; and Cialis can work up to 36 hours. These drugs must be prescribed by a doctor and are not suitable for everyone with erectile dysfunction. Your doctor will determine if you have ED and will decide if one of these drugs is right for you.

Men who have suffered a heart attack, stroke, or arrhythmia (irregular heartbeat) should not take ED drugs, and if you have uncontrolled low or high blood pressure or have chest pain during sex, you should avoid these drugs. Some of the common side effects include headache, heartburn, flushing, nasal congestion, changes in vision, and back pain. More serious adverse effects and ones that require immediate medical attention are rash, painful erection, prolonged erection, fainting, chest pain, and itching/burning during urination.

If you would like to learn more about the possible negative side effects of erectile dysfunction drugs, please contact the Law Offices of Michael J. O'Connor & Associates at 800-518-4529 or visit our website to fill out one of the contact forms (http://www.oconnorlaw.com/). The initial consultation is free, and we work on a contingency basis. We don't get paid unless we win your case.

posted by Michael J. O'Connor & Associates at 10:32 AM

Wednesday, August 15, 2007

PharmaFab

PharmaFab, a distributor of more than 100 different drug products, has entered a legal agreement with the FDA under which they will stop the illegal manufacture and distribution of prescription and over-the-counter drugs. In the past, PharmaFab has sold items not made according to the current good manufacturing practice (CGMP), and many of its products did not have the required FDA approval.

PharmaFab has also been ordered to destroy all their illegal drugs and is barred from distributing all drug products until it fully complies with CGMP and gets the required FDA approval.

Just a few of the drugs distributed by PharmaFab include:

Rhinacon A Tablets
Sudal 12 Chewable Tablets
Atuss HX CIII
Histex PD 12 Suspension
De-Congestine Sustained Release Capsules

For more information, contact the Law Offices of Michael J. O'Connor & Associates at 800-518-4529, or visit our website to fill out one of the contact forms (www.oconnorlaw.com). The initial consultation is free and the firm works on a contingency fee basis, so you pay nothing unless we recover money for you.

posted by Michael J. O'Connor & Associates at 11:57 AM

Wednesday, August 08, 2007

FDA Recommends Medical Device User Fee Program

The FDA has proposed a recommendation to Congress for reauthorizing the Medical Device User Fee and Modernization ACT (MDUFMA), which would help to ensure that safe and effective medical devices get to patients in a timely fashion. Under this program, industry covers a portion of the costs of the FDA's pre-market review program through a variety of fees. The additional revenues generated from the fees paid by the medical device industry would continue to be used to ensure patients have timely access to safe and effective medical devices.

This proposal, if adopted, would foster the development of innovative in vitro diagnostic tests by issuing new industry guidance on emerging issues and reviewing some low-risk devices to determine whether any of them could be exempted from the need for product review.

The Medical Device User Fee and Modernization Act of 2002, which expires on September 30, 2007, amended the federal Food, Drug and Cosmetic Act to provide the FDA with new responsibilities and resources to keep with the rapidly growing device industry and advancing medical device technology.

For more information, contact the Law Offices of Michael J. O'Connor & Associates at 800-518-4529 or visit our website to fill out one of the contact forms (http://www.oconnorlaw.com/). The initial consultation is free and the firm works on a contingency fee basis, so you pay nothing unless we recover money for you.

posted by Michael J. O'Connor & Associates at 1:32 PM

Wednesday, August 01, 2007

CONGRATULATIONS!!

Donna DeBellis of Tamaqua is our official Newsletter Email To WIN! winner. Donna and a guest will be going to the Philadelphia Phillies game on Sunday, September 9 vs. the Florida Marlins. Congratulations - Enjoy the Game!!

posted by Michael J. O'Connor & Associates at 9:53 AM

Previous Posts

Archives